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ABSTRACT: Breast cancer is one of the leading causes of death from cancer
among women in western countries. The different types of breast cancer are
grouped into invasive and noninvasive forms. Among the invasive types, ductal
infiltrating carcinoma (DIC) is the most common and aggressive form. Using
an in vitro model consisting of a DIC-derived cell line (8701-BC) and a non-
tumoral mammary epithelial cell line (HB2), we used the proteomics approach
to search for homology and differences in protein expression patterns between
tumoral and nontumoral phenotypes. Within an analysis window comprising
1,750 discernible spots we have currently catalogued 140 protein spots of po-
tential interest. Fifty-eight of them were identified by gel matching with refer-
ence maps, immunodetection, or N-terminal microsequencing and classified
into four functional groups. Twelve proteins were found differentially ex-
pressed in two cell lines: four were uniquely present in the neoplastic cell pro-
teome and eight in epithelial cells. In addition, 53 proteins displayed different
relative expression levels between the two cell lines, that is, 44 were more ele-
vated in cancer cells and 9 in HB2 cells. Among proteins with greater relative
abundance in cancer cells we identified glycolytic enzymes (or their isoforms),
which may indicate that the known metabolic dysregulation in cancer can re-
flect oncogenic-related defects of glycolytic gene expression.
KEYWORDS: proteomics; breast cancer; ductal infiltrating carcinoma
INTRODUCTION
Cancer of the mammary gland is still one of the leading causes of death from tu-
mor among women in western countries. However, breast cancer is not a single dis-
ease but includes several different forms grouped as invasive and noninvasive types.
Among the invasive histotypes, ductal infiltrating carcinoma (DIC) is the most com-
mon and aggressive form of breast cancer.1 It usually has a poor prognosis and rep-
resents the standard histotype with which the other less frequent subtypes (i.e.,
papillary, mucinous-colloid, tubular, medullary carcinomas) are compared. Carcino-
mas are potentially malignant tumors of epithelial origin, which, once genetically
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“initiated,” grow, progress, invade, and spread in the body with a common phenom-
enology regardless of their individual derivation.
The major cellular changes involved in the conversion of a normal to a malignant
breast are the progressive loss of the stationary epithelial phenotype (consisting of
polarized morphology and specific cell-cell and cell-matrix adhesion systems) and
the acquisition of a mesenchymal-like phenotype, correlated with the ability to mi-
grate and invade surrounding and distant tissues, even under conditions of a low ox-
ygen supply. These aspects are related to multiple gene defects, whose functional
network is hard to understand from a global point of view.
According to recent estimation, the human genome encodes at least 30,000–
40,000 structural genes.2,3 However, due to posttranscriptional and posttranslational
modifications, the number of proteins expressed by cells may be several times high-
er. In addition, posttranslational modifications may be instrumental in altering or
adding functions to certain proteins and their oligomeric forms. Therefore, detecting
protein profiles, directed towards knowledge of both the identity and the relative
quantity of proteins (and their isoforms) in tumors, is the challenge of the post-
genomic era. Comparative profiling of paired tumoral and normal counterparts may
provide substantial information on qualitative and quantitative modifications of
cancer-associated gene expression, which in turn can be fundamental in understand-
ing molecular mechanisms involved in cancer development. The proteomic strategy,
based on a high-resolution two-dimensional immobilized pH gradient (2D-IPG) and
related techniques (computer-assisted image analysis, microsequencing, and im-
mune detection), is a powerful tool for the separation, detection, and analysis of a
large number of proteins on the same preparation, without prior knowledge of their
identity.
The study of protein expression in primary human breast cancer (as for most solid
tumors), however, is difficult because breast tumors may contain several different
cell types, other than carcinoma cells, such as additional epithelial cell types, stromal
cells, and infiltrating lymphocytes. On the other hand, laser-capture microdissected
sections4 may contain large amounts of proteins resident in the extracellular intersti-
tium as albumin, globulins, and other serum proteins. Therefore, several laborato-
ries, including ours, have developed an appropriate in vitro model of normal and
neoplastic mammary cells for biological and molecular assays5–8 including the
recent approach on cDNA microarray9 and proteomics.10
Among the breast cancer cell lines described to date in the literature, 8701-BC5
deserves particular interest, because it was established from a primary DIC, that is,
before clonal selection of the metastatic process. As a nontumoral reference cell line,
we used HB2 cells7 that maintain in culture the lumenal mammary phenotype, which
represents the most common target of mammary cancer.
On protein separation by 2D-IPG and computer processing of the 2D gels, we
searched for qualitative (presence/absence) and quantitative (relative abundance)
differences in protein profiles to identify relevant differences and homologies
between the two representative cell lines.
Within an analysis window comprising about 1,750 discernible spots, we have
currently catalogued 140 proteins of potential interest, 58 of which were identified
by gel matching, immunodetection, or N-terminal microsequencing. Twelve pro-
teins were differentially expressed in the two cell lines: four were expressed unique-
ly by neoplastic cells and eight by epithelial cells. In addition, 53 proteins of 140
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selected in the map displayed different relative quantities, namely, 44 proteins were
more elevated in cancer cells and 9 in HB2 cells.
Interestingly, among proteins with higher relative expression levels in cancer cells
(at least 1.5- to 3-fold) we identified several glycolytic enzymes and their isoforms.
This finding is of interest, because the “Warburg effect” (enhanced anaerobic metabo-
lism in cancer) has long been known, but this is the first report of increased levels of
these enzymes in cancer cells at the proteomic level. Therefore, due to their easy de-
tection on the 2D map, the present approach could have great clinical application.
MATERIAL AND METHODS
Cell Culture
Cells were grown in the appropriate culture medium supplemented with 10%
fetal calf serum (FCS; GIBCO) and antibiotics (100 units/ml penicillin and 100 µg/
ml streptomycin) in a humidified incubator with 3% CO2 in air at 37°C. The culture
medium was RPMI 1640 for the 8701-BC5 and Dulbecco’s modified Eagle’s medi-
um (DMEM) supplemented with hydrocortisone (5 µg/ml) and insulin (10 µg/ml)
for the HB2 human mammary epithelial cell line.7
Sample Preparations
Cells were grown to confluence and then incubated with three changes of serum-
free medium. After washing with ice-cold phosphate-buffered saline solution, they
were carefully scraped and incubated in ice for 30 minutes with RIPA buffer (50 mM
Tris pH 7.5, 0.1% nonidet P-40, 0.1% deoxycholate, 150 mM NaCl, 4 mM EDTA,
and a mixture of protease inhibitors, 0.01% aprotinin, 10 mM sodium pyrophos-
phate, 2 mM sodium orthovanadate, and 1 mM PMSF). The total cellular lysate was
centrifuged at 14,000 rpm for 8 minutes to clear cell debris, and the supernatant was
dialyzed against ultrapure distilled water, lyophilized, and stored at −80°C until
analysis. Protein concentration in the cellular extracts was determined using the
Breadford method.
Two-Dimensional Gel Electrophoresis
Aliquots of dried cell lysate were solubilized in buffer containing 8 M urea, 4%
CHAPS, 40 mM Tris, 65 mM DTE (1,4-dithioerythritol), and trace amounts of bro-
mophenol blue.
The first dimensional separation was performed at 20°C on commercial sigmoi-
dal immobilized pH gradient strips (IPG) 18 cm long, pH 3.5–10 (Pharmacia), es-
sentially as described by Görg et al.11 and Bjellqvist et al.12 Strips were rehydrated
in 8 M urea, 2% CHAPS, 10 mM DTE, and 0.5% carrier ampholytes (resolyte 3.5–
10). Aliquots of 45 µg (analytical gels) or 1.5 mg (preparative gels) total proteins
were applied to the gel strip. Isoelectrofocusing was carried out by linearly increas-
ing voltage from 200–3,500 V during the first 4.5 hours, after which focusing was
continued at 8,000 V for 8 hours. After the run, the IPG strips were equilibrated with
a solution containing 6 M urea, 30% glycerol, 2% SDS, 0.05 M Tris-HCl pH 6.8, and
2% DTE for 12 minutes to resolubilze proteins and reduce disulfur bonds. The -SH
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groups were then blocked by substituting the DTE with 2.5% iodoacetamide in the
equilibrating buffer.
The focused proteins were then separated on 9–16% linear gradient polyacryla-
mide gels (SDS-PAGE) with a constant current of 40 mA/gel at 10°C. Gels were
stained with ammoniacal silver nitrate, as described by Hochstrasser et al.13
Image Acquisition and Data Analysis
Silver-stained gels were digitized using a computing densitometer and processed
with a Melanie 3 computer system (GeneBio). Gel calibration was carried out on the
basis of internal standard with the support of the ExPaSy molecular biology server.
Quantitative variations of proteins were expressed as volumes of spots (i.e., integra-
tion of optical density over the spot area). To correct for differences in gel staining,
relative volumes to the sum of the volume of all spots in each gel were calculated
with the Melanie system and plotted with the Excel program. For figure presentation,
images were transferred to Adobe Photoshop and PowerPoint programs.
Protein Microsequencing
N-terminal microsequencing was performed by automated Edman degradation in
an Applied Biosystem protein sequenator (Procise, Perkin-Elmer) on protein sam-
ples electrotransferred onto polyvinylidene difluoride membranes (Immobilon-
PTM, Millipore). The SWISS-PROT (ScanProsite) and EMBL (Bic 2) databases
were used for online sequence similarity search at http://expasy.hcuge.ch/.
RESULTS
The In Vitro Model
As an in vitro model for present research, we used two representative cell lines:
the 8701-BC, derived from a primary ductal infiltrating carcinoma,5 which shows in-
vasive behavior both in vivo and in vitro,14–16 and the nontumorigenic HB2 cell line,
derived from immortalized human lumenal mammary epithelial cells,7 kindly sup-
plied by Dr. J. Taylor-Papadimitriou (Imperial Cancer Research Fund, London, Unit-
ed Kingdom) and presently cultivated in our laboratory.
FIGURE 1 shows representative phase-contrast micrographs of the two cell cul-
tures at the following time of growth: 24 hours, 48 hours, 72 hours, and 1 week after
seeding. As can be observed in the micrographs from A to D, the neoplastic cells dis-
play an apolarized morphology with irregular profiles; they spread over the substrate
with emission of spikes and once they reach confluence, they overgrow, forming typ-
ical domes (FIG. 1D). On the contrary, HB2 cells (FIG. 1E–H) maintain in vitro the
morphology of epithelial cells, being polarized and responsive to contact inhibition.
Proteomic Profiles of the 8701-BC and HB2 Cell Lines
Each cell culture was grown until confluence, deprived of serum, and then pro-
cessed for lysis and two-dimensional-IPG separation, as described in Material and
Methods. FIGURES 2 and 3 show the miniature of two representative 2D maps of the
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FIGURE 1. Phase contrast micrographs of 8701-BC cells (A, B, C, and D) and HB2 cells
(E, F, G, and H) at different times from seeding: 24 hours, 48 hours, 72 hours, and 1 week,
respectively. Note the different pattern of cell growth and morphology: HB2 cells maintain in
culture a polarized morphology and contact inhibition, differently from neoplastic cells, which
show apolarized morphology and form multilayered “domes” in the absence of contact inhi-
bition. The two cell lines were confluent at the time of the experiments (600×).
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8701-BC and HB2 cells, respectively. The crosses on the spots as well as the grid
indicating pI and Mr were assigned by the Melanie system after cleaning out the
background from maps. The number of spots was 1,747 in cancer cells and 1,753 in
HB2 cells.
Protein Identification and Clustering in the 8701-BC Map
Protein identification in the 8701-BC map was performed by gel matching, im-
munodetection, or N-terminal microsequencing, as described in Material and
Methods. Currently, 58 proteins (including isoforms) were identified in the map and
grouped according to their major functions. The first group includes cytoskeletal
proteins, the second group folding, chaperons, and heat-shock proteins, the third
FIGURE 2. Representative two-dimensional electrophoretogram of proteins in 8701-
BC cell line. Crosses and grid indicating pI and Mr were automatically assigned by the
Melanie system.
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group proteins involved in metabolism and biosynthesis, and the fourth group pro-
teins and enzymes with regulatory functions. TABLES 1 to 4 list the protein groups,
where proteins are indicated by the abbreviations used by the Swiss-Prot database.
For each protein the accession number, pI, and Mr and the method of identification
are given. When more isoforms of the same protein are present, alphabetical letters
are added to the protein name abbreviation .
Proteome Comparison between 8701-BC and HB2 Cells
A representative number of 140 spots was arbitrarily selected to achieve un-
ambiguous gel matching between the two maps. This number represents a significant
FIGURE 3. Representative two-dimensional electrophoretogram of proteins in the
HB2 cell line matched with the 8701-BC profile.
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subset of proteins in the proteomic map, corresponding to about 8% of the total
amount, and includes the proteins already identified and proteins with unknown
identity (U), because they were absent from the data banks or N-terminal blocked.
Their identification will be the object of further studies .
Triplicate experiments were performed to ensure reproducible protein separation;
to exclude ambiguous spots, synthetic gels of the two cell preparations were con-
structed by means of the Melanie algorithms. FIGURE 4 shows the synthetic gel of
the 8701-BC cell preparation and FIGURE 5 that obtained from HB2 cells. The iden-
TABLE 1. Cytoskeletal proteins
Protein AC pl Mr ID method
ACTB a P02570 5.16 42,000 GM
ACTB b P02570 5.2 42,000 GM
ACTB c P02570 5.23 42,000 GM
CK 8 P05787 5.09–5.72 42,000–49,830 WB
CK 18 P05783 5.05–5.61 47,074–51,800 WB
EZRI P15311 6.04 75,194 GM
TBB2 P05217 4.98 49,913 GM
TABLE 2. Folding, chaperones, and heat shock proteins
Protein AC pl Mr ID method
CBP2 a P50454 9.23 49,309 GM
CBP2 b P50454 9.38 49,363 GM
CRTC P27797 4.52 59,300 GM
CYPH a P05092 6.66 14,500 GM
CYPH b P05092 7.07 14,500 GM
CYPH c P05092 7.51 14,500 GM
ERP60 P30101 5.88 53,600 Nt-Ms
GRP 75 a P38646 5.24 68,300 GM
GRP 75 b P38646 5.03 68,300 GM
GRP 78 a P11021 4.99 73,100 GM
GRP 78 b P11021 5.02 73,100 GM
GRP 78 c P11021 5.04 73,100 GM
HSP 60 a P10809 5.19 59,500 GM
HSP 60 b P10809 5.21 59,500 GM
HSP 60 c P10809 5.27 59,500 GM
PDI P07237 4.84 56,700 GM
TCPZ P40227 6.2 58, 397 GM
TRA P14625 4.9 91,200 GM
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TABLE 3. Proteins involved in metabolism and biosynthesis
Protein AC pl Mr ID method
ALFA a P04075 7.74 38,100 GM
ALFA b P04075 7.95 38,100 GM
ENOA a P06733 6.41 47,074 WB
ENOA b P06733 6.59 47,074 WB
ENOA c P06733 6.85 46,635 WB
ENOA tr … 6.87 41,511 Nt-Ms
G3P2 a P04406 7.22 34,381 Nt-Ms
G3P2 b P04406 8.02 35,500 Nt-Ms
G3P2 c P04406 8.07 35,500 Nt-Ms
G3P2 d P04406 8.26 35,652 Nt-Ms
G3P2 e P04406 8.47 35,959 Nt-Ms
G3P2 tr … 8.38 32,468 Nt-Ms
KPY 1 P14618 7.12 59,300 GM
KPY 2 P17786 7.28 59,300 GM
TPIS a P00938 6.51 25,000 GM
TPIS b P00938 6.81 25,000 Nt-Ms
GSTP P09211 6.01 21,054 Nt-Ms
SODM P04179 6.96 21,600 GM
ACON Q99798 6.91 79,190 GM
MDHM P40926 8.17 33,835 Nt-Ms
MA32 Q07021 4.54 28,600 Nt-Ms
EF1B P24534 4.62 29,200 GM
EFTU P49411 6.51 43,300 Nt-Ms
RM12 P52815 5.11 15,820 GM
TABLE 4. Proteins and enzymes with regulatory functions
Protein AC pl Mr ID method
ANX1 P04083 7.08 32,075 Nt-Ms
ANX1-like … 7.89 26,932 Nt-Ms
MIF P14174 7.62 11,900 GM
P53 P04637 6.79 49,039 GM
PSA5 P28066 4.77 25,900 Nt-Ms
TCTP P13693 4.89 22,100 GM
THIO P10599 5.02 12,919 Nt-Ms
UBIQ P02248 6.89 8,700 GM
UBL 1 P09936 5.34 23,940 Nt-Ms
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tified proteins are indicated with abbreviations used by the Swiss-Prot database; the
spots corresponding to proteins with unknown identity are indicated with numbers.
Qualitative differences (presence/absence of spots) were observed within both
groups of proteins with known and unknown identity. Proteins present in cancer cells
and absent in the HB2 cell map were: the ubiquitin carboxyl-terminal hydrolase
isozyme (UBL 1), an isoelectric variant of glutathione S-transferase (GSTP), and
two proteins with unknown identity (spot numbers 35 and 36). Conversely, eight
spots out of the panel of those selected (namely, 2a, 2b, 2c, 51a, 54, 65a, 65b, and
65c) were uniquely present in the HB2 cell map. (Note that arrows point to corre-
sponding positions of the expected spot, even in the absence of discernible stain.)
After qualitative analysis, we performed comparative quantitation of the compre-
hensive spectrum of selected protein spots, except the cytokeratins, which were iden-
tified by separate western blot analysis (not shown). The comparison was made by
FIGURE 4. Synthetic gel created after elimination of background features from two-di-
mensional gels of 8701-BC cells. The proteins identified in triplicate gels are indicated with
the abbreviations used in the Swiss-Prot database. The letters following the protein names in-
dicate different isoforms. The numbers correspond to protein spots with unknown identity.
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plotting the relative abundance (%Vol, average of triplicate experiments) of spots
from the 8701-BC versus the corresponding spots of the HB2 cell map ordered ac-
cording to increasing values (graphs 6 and 7) or vice versa (graph 8). The graph in
FIGURE 6 shows the comparative profiles of known proteins, and the graphs in FIG-
URES 7 and 8 those of proteins with unknown identity.
As can be observed in the histograms, the profiles of the sampled protein are no-
tably distinct in the two cell lines, because about 37% of the selected protein spots
displayed variable levels of relative abundance in the two proteomes; in particular,
44 were overexpressed in cancer cells and 9 in epithelial cells, whereas the remain-
der displayed similar levels of expression in both maps.
FIGURE 5. Synthetic gel created after elimination of background features from two-
dimensional gels of HB2 cells matched to the neoplastic cell profile. Note that in both maps
some arrows point to corresponding positions of the expected spots, even in the absence of
discernible stain.
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Proteins that showed higher intensity in cancer cells included glycolytic en-
zymes, chaperonins, and others with specific roles in biosynthesis and cellular me-
tabolism. Conversely, no significant differences were found among the group of
cytoskeletal proteins.
Among the glycolytic enzymes, glyceraldehyde-3-phosphate dehydrogenase
(G3P2) showed an average increase of 1.5-fold relative to the control map. However,
the various isoforms increased to a different extent, with the highest level of 2.5-fold
exhibited by isoform c (TABLE 3). Similarly, alpha-enolase displayed an average in-
crease of 1.7-fold, with the greatest difference for isoform c. An increment was also
observed for fructose bisphosphate aldolase (1.37-fold for ALFA a and 1.5-fold for
isoform b) and for pyruvate kinase (1.74-fold for KPY1 and 1.9-fold for KPY2). By
contrast, no essential differences were observed for triosephosphate isomerase
(TPIS).
Among the group of chaperonins, one isoform of mitochondrial molecular chap-
erone heat-shock protein 60 (HSP60) was found almost differentially present in can-
cer cells, whereas disulfide isomerase ER-60 (ERP 60) and peptidil prolyl cis-trans
isomerase (CYPH) showed increased levels of about twofold. A similar difference
was found for elongation factor Tu (EFTU), thioredoxin (THIO), superoxide dismu-
tase (SOD), oncosuppressor p53, and the MA32 glycoprotein, all proteins that play
an active role in controlling cell proliferation and biosynthesis. Conversely, tumor
rejection antigen 1 (TRA) and collagen binding protein (CBP2) were more
expressed in HB2 cells.
Concerning proteins of unknown identity (marked U followed by the number as-
signed in the 2D maps in FIGS. 2 and 3), two were uniquely present in cancer cells,
as already mentioned (U35 and U36), and 22 were highly overexpressed (FIG. 7).
The proteins overexpressed, or uniquely present, in epithelial cells relative to cancer
cells are shown in FIGURE 8. 
DISCUSSION
The proteomic strategy, based on two-dimensional gel electrophoresis and related
techniques for protein identification and quantification, is a growing field of research
in a world-wide dimension. However, comprehensive protein profiling in cancer oc-
curs at its beginning. This work has contributed to the knowledge of breast cancer
FIGURE 6. Histogram showing a pattern of differentially expressed proteins between
neoplastic and normal epithelial cells. Values in the ordinate represent the percentage of vol-
ume (integration of outer diameter [OD] over the feature’s area) of individual spots over the
sum of total spot volumes in each map. Bars indicate the standard deviation of triplicate
measurements, which were 5–10%. Correspondence between numbers (Nr) in the abscissa
and protein identity (ID) is given in the table below the graph.
FIGURE 7. Relative abundances (Vol%) of a subset of protein spots with unknown
identity, which are differentially expressed in normal and neoplastic cells. Graph highlights
the protein spots more abundant in cancer cells relative to HB2 cells. The table below the
graph lists the number of protein spots (corresponding to that assigned in the maps in FIGS.
5 and 6), with the pI and Mr coordinates. Standard deviation (not shown) of triplicate mea-
surements was 5–10%.
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proteomics, using an in vitro model consisting of the well-characterized breast can-
cer cell line 8701-BC5 and a human mammary epithelial cell line, HB2.7
Within the limitation of cultured cells, the two cell lines represent a suitable mod-
el, because each of them maintains in culture the specific features of their original in
vivo status: HB2 cells display a polarized phenotype and are responsive to contact
inhibition, whereas 8701-BC cells have pleomorphic morphology and overgrow,
forming typical domes. Both of them express cytokeratin 8 and 18, which is typical
of lumenal mammary cells. However, 8701-BC cells display isoelectric variants of
the two cytokeratin forms, which are absent in normal cells (work in progress).
Within the experimental window of the 2D-IPG used, an average of 1,750 spots
was detected by the Melanie system. To establish a significant area of overlapping
between maps, we arbitrarily chose a subset of 140 representative spots, covering the
8% of the total protein complement in the maps. Fifty-eight proteins (including iso-
forms) were identified by gel matching with reference maps, immunodetection, or
N-terminal microsequencing and were classified according to their major functions.
Of these, 9 belong to the class of cytoskeletal proteins, 18 to chaperonins and affine
proteins, 23 are proteins involved in metabolism and biosynthesis, and 8 are involved
in regulatory functions.
Results of computer-assisted matching of the neoplastic cell protein profile ver-
sus the normal epithelial cell profile demonstrated that within our selected protein
sample, 12 proteins, four of which were uniquely present in the cancer cells, were
differentially expressed in the two cell lines. Among these were isoelectric variants
of glutathione S-transferase (GSTP) and the ubiquitin carboxyl-terminal hydrolase
isozyme (UBL 1). The latter is a thiol protease involved in the processing of both
ubiquitin precursors and ubiquinated proteins. It is interesting that this enzyme was
originally found in neurons and cells of the diffuse neuroendocrine system and their
tumors; therefore, its presence and function in breast cancer cells deserve further
study.
In measuring changes in relative intensity within the subset of 140 protein spots,
we found differences in about 37% of them, that is, 44 proteins were more elevated
in cancer cells and 9 in epithelial cells.
Interestingly, most proteins overexpressed in cancer cells belong to the group of
glycolytic enzymes. Elevated levels of anaerobic metabolism, even in the presence
of oxygen, known as the “Warburg effect” after the scientist’s discovery seven de-
cades ago, are a frequent clinical syndrome in oncologic patients.13 However, the
relative increment in glycolytic enzymes (or their isoforms) at the protein expression
level was unexpected, because they are thought to be constitutively expressed by
cells; in particular, G3P2 is used as one of the housekeeping genes to normalize tran-
scriptional levels of other messengers in several experimental models.
Comparing our breast cancer cell map with that available on line (http://www.ex-
pasy.ch/ch2d/), we found that DIC tissues17 consistently and reproducibly show in-
FIGURE 8. Relative abundance of the same group of protein spots shown in the previ-
ous figure. The graph highlights a subset of protein spots more abundant in HB2 cells than
in neoplastic cells. The table below shows the numbers of protein spots (corresponding to
the maps in FIGS. 5 and 6) with the pI and Mr coordinates. The standard deviation (not
shown) of triplicate measurements was 5–10%.
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creased levels of glycolytic enzymes in comparison with paired healthy tissues of the
same patients. This observation allows us to conclude that the increased level of gly-
colytic enzymes in vivo is also maintained in cultured cancer cells and therefore may
represent part of early oncogenic transformation in cancer rather than a mere adap-
tive response of tumor cells to the low oxygen supply in the host microenvironment.
This hypothesis is supported by recent molecular studies revealing that several of
the multiple genetic alterations involved in tumor development directly affect glyc-
olysis, which in turn increases the ability of tumor cells to recruit new blood vessel
metabolism (Ref. 18 and references therein).
In conclusion, our current data have contributed to the knowledge of proteomic
profiling of breast cancer cells. While indicating homologies with data already re-
ported in vivo, they add new information on cancer-related proteomics, the knowl-
edge of which will greatly enhance our understanding of molecular pathways
involved in cancer development.
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